Dec 16, 2021 / 01:30PM GMT
Bruce N. Jacobs - Kymera Therapeutics, Inc. - CFO
Good morning. I'm Bruce Jacobs, Kymera's Chief Financial Officer. It's my great pleasure to welcome everyone to Kymera's first ever R&D Day, which is being broadcast from our headquarters in Watertown, Massachusetts.
As you may have seen this morning, we issued a press release with highlights of today's meeting. That release is also available on our website. Following the completion of today's session, we'll post both the R&D Day slide deck and the video replay of all presentations to the Events and Presentations section of our website.
Our plan today is to spend the next 2 hours sharing a number of important program and platform updates, as well as new clinical data from the MAD portion of our IRAK 4 Phase I trial. We also hold time at the end of our prepared remarks, likely around 10:30 this morning to take your questions. You'll note there's a question submission bar on your screen that will be opened through the presentations this morning and during the Q&A session. We will collect those questions throughout the morning
Kymera Therapeutics Inc To Host Virtual R&D Day Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers